This content is from: Portfolio Market Turmoil Hits Valuations of Late-Stage Venture Capital While deals are still closing, the most expensive transactions are the most vulnerable to macroeconomic issues such as inflation, rising rates, and geopolitical tensions. By Jessica Hamlin May 12, 2022
This content is from: Portfolio Is the Venture Capital Market on the Verge of a Decline? As the public markets continue to wane, PitchBook expects nontraditional investors to loosen their grip on VC deals. By Jessica Hamlin April 06, 2022
This content is from: Portfolio Allocators Want Access to Top Startups Without All the Competition. Venture Debt May Be the Answer. The market is much quieter than venture capital — but that’s not likely to last for long. By Alicia McElhaney March 29, 2022
This content is from: Portfolio King Street: Venture Debt Offers a Way Around Slowing Valuations Start-ups want to avoid “down rounds.” Credit manager King Street says debt — or growth lending — is one answer. By Alicia McElhaney April 19, 2022
This content is from: Portfolio Why Investors Should Say No to Tech IPOs In the last decade, late-stage investments made before companies go public have generated the highest alpha. By Hannah Zhang May 10, 2022
This content is from: Premium Life Sciences Venture Investments Still Have a Pulse Several leading hedge funds specializing in life sciences and biopharma have been more active in the private markets this quarter. But overall volume is still way down from the highs. By Stephen Taub March 24, 2022
